Results 261 to 270 of about 675,326 (300)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 1998
Despite the many advances reported during the past year, pancreatic cancer remains a profound therapeutic challenge. Helical CT has become the preferred staging study at many institutions. The role of chemoradiation therapy in a preoperative and postoperative setting is being defined. Gemcitabine has become first-line therapy for patients with advanced
R E, Brand, M A, Tempero
openaire +4 more sources
Despite the many advances reported during the past year, pancreatic cancer remains a profound therapeutic challenge. Helical CT has become the preferred staging study at many institutions. The role of chemoradiation therapy in a preoperative and postoperative setting is being defined. Gemcitabine has become first-line therapy for patients with advanced
R E, Brand, M A, Tempero
openaire +4 more sources
Journal of Gastroenterology and Hepatology, 2000
Abstract The incidence of pancreatic adenocarcinoma in the USA remains stable. Advances in management are confined to more accurate preoperative diagnosis and staging, and decreased operative mortality. Long‐term survival in the absence of resection remains poor.
S J, Cohen +3 more
openaire +4 more sources
Abstract The incidence of pancreatic adenocarcinoma in the USA remains stable. Advances in management are confined to more accurate preoperative diagnosis and staging, and decreased operative mortality. Long‐term survival in the absence of resection remains poor.
S J, Cohen +3 more
openaire +4 more sources
The Biomedical & Life Sciences Collection, 2004
Pancreatic cancer remains a major unsolved health problem, with conventional cancer treatments having little impact on disease course. Almost all patients who have pancreatic cancer develop metastases and die. The main risk factors are smoking, age, and some genetic disorders, although the primary causes are poorly understood.
Donghui, Li +3 more
openaire +4 more sources
Pancreatic cancer remains a major unsolved health problem, with conventional cancer treatments having little impact on disease course. Almost all patients who have pancreatic cancer develop metastases and die. The main risk factors are smoking, age, and some genetic disorders, although the primary causes are poorly understood.
Donghui, Li +3 more
openaire +4 more sources
Pancreatitis and Pancreatic Cancer
Primary Care: Clinics in Office Practice, 2017Most cases of acute pancreatitis are related to gallstones. More than 80% resolve within a few days. The diagnosis is based on upper abdominal pain, elevated lipase and/or amylase, and transabdominal ultrasound findings. Management requires early aggressive hydration, pain control, nutritional support, and monitoring for progression.
Anne, Walling, Robert, Freelove
openaire +2 more sources
Autoimmune pancreatitis mimicking pancreatic cancer
Journal of Hepato-Biliary-Pancreatic Sciences, 2009Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis that can often be difficult to distinguish from pancreatic cancer. We describe the clinical and radiographic features of 23 patients with AIP whose presentations mimicked pancreatic cancer.A review of clinic, radiology, and endoscopy records from a 6-year period identified patients with ...
Lindsay S, Robison +5 more
openaire +2 more sources
The Lancet
Pancreatic cancer is frequently a lethal disease with an aggressive tumour biology often presenting with non-specific symptoms. Median survival is approximately 4 months with a 5-year survival of 13%. Surveillance is recommended in individuals with familial pancreatic cancer, specific mutations, and high-risk intraductal papillary mucinous neoplasm, as
Thomas F, Stoop +6 more
openaire +2 more sources
Pancreatic cancer is frequently a lethal disease with an aggressive tumour biology often presenting with non-specific symptoms. Median survival is approximately 4 months with a 5-year survival of 13%. Surveillance is recommended in individuals with familial pancreatic cancer, specific mutations, and high-risk intraductal papillary mucinous neoplasm, as
Thomas F, Stoop +6 more
openaire +2 more sources
Chronic Pancreatitis and Pancreatic Cancer
New England Journal of Medicine, 1993Pancreatic cancer is the 5th leading cause of death from cancer and the 11th most common cancer in the United States1; each year 24,000 people die of pancreatic cancer in this country. The incidence of pancreatic cancer increased dramatically several decades ago, but it has remained fairly stable over the past 15 years (9.1 per 100,000).
E B, Gold, J L, Cameron
openaire +2 more sources
Pancreatic sarcoidosis mimicking pancreatic cancer
Journal of Clinical Ultrasound, 1988Etude echographique et tomodensitometrique.
B R, Sagalow, C L, Miller, R J, Wechsler
openaire +2 more sources